pivekimab sunirine
immunogen
['cadenza', 'pivekimab', 'immunogen ', '$imgn']
immunogen presents updated findings from cadenza trial of pivekimab sunirine in blastic plasmacytoid dendritic cell neoplasm at eha 2023 congress $imgn 6.35% via 
Managed Corporate Credit currently a Trader / Investor. Mostly using my Feed to Journal my DayTrading Notes. Watch List Summary Posted Most Weekdays by 9am EST.